about
Cardiovascular Gene Therapy: Past, Present, and Future.Stem Cell-Derived Exosomes, Autophagy, Extracellular Matrix Turnover, and miRNAs in Cardiac Regeneration during Stem Cell Therapy.Pursuing meaningful end-points for stem cell therapy assessment in ischemic cardiac disease.Global position paper on cardiovascular regenerative medicineFuture directions for therapeutic strategies in post-ischaemic vascularization: a position paper from European Society of Cardiology Working Group on Atherosclerosis and Vascular Biology
P2860
description
2015 nî lūn-bûn
@nan
2015 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Endpoints in stem cell trials in ischemic heart failure
@ast
Endpoints in stem cell trials in ischemic heart failure
@en
Endpoints in stem cell trials in ischemic heart failure
@nl
type
label
Endpoints in stem cell trials in ischemic heart failure
@ast
Endpoints in stem cell trials in ischemic heart failure
@en
Endpoints in stem cell trials in ischemic heart failure
@nl
prefLabel
Endpoints in stem cell trials in ischemic heart failure
@ast
Endpoints in stem cell trials in ischemic heart failure
@en
Endpoints in stem cell trials in ischemic heart failure
@nl
P2093
P2860
P921
P1476
Endpoints in stem cell trials in ischemic heart failure
@en
P2093
Andre Terzic
Atta Behfar
Branko Beleslin
Jozef Bartunek
Marc Vanderheyden
Marko Banovic
Zlatibor Loncar
P2860
P2888
P356
10.1186/S13287-015-0143-9
P407
P5008
P577
2015-08-29T00:00:00Z
P5875
P6179
1037354354